Refill hormone and TRT pricing

How does Refill price hormone and TRT medications?

Refill prices compounded hormones and TRT medications through pre-negotiated aggregate 503A rates across its pharmacy network, plus tiered software fees on transactions published at roughly 1.5–5% depending on platform tier. Per-vial hormone cost is confirmed at demo rather than on a public catalog. For TRT and HRT programs, the economic question is not just the starting rate but whether aggregate pricing and software fees stay stable across monthly or multi-week refill cadences as patients remain on therapy for years.

This page explains hormone and TRT cost drivers on Refill, why rate stability matters on recurring programs, and how pass-through pricing handles long-horizon margin planning.

Compare Fizy Health vs Refill
TRT and HRT programs Recurring refill cadence Aggregate hormone rates Software fees every refill Rate stability Pass-through alternative

Why hormone pricing is a long-horizon question on Refill

TRT and HRT patients refill for months or years, not weeks. Refill hormone economics combine aggregate pre-negotiated 503A rates with a software fee on every recurring transaction within published tiers. A competitive testosterone cypionate or estradiol rate at onboarding matters less if aggregate rates renegotiate at volume tiers or meet-or-beat terms expire. Multi-line hormone panels compound software fees across several SKUs per patient per cycle. Landed-cost planning for hormone programs requires written confirmation on rate stability, not just a headline demo quote on your starting formulary.

Questions for recurring hormone and TRT programs

Ask for written per-vial cost on every hormone SKU in your standard TRT or HRT panel, not just testosterone alone. Ask whether aggregate rates are fixed across refill cycles or subject to renegotiation at volume tiers. Ask how software fee percentage applies to multi-line hormone orders when a patient gets testosterone plus anastrozole plus hCG in one checkout. Ask whether meet-or-beat guarantee terms cover hormone SKUs and for how long matched rates hold.

Model a twelve-month cohort: multiply per-vial hormone cost plus software fee across expected refills per patient, then across active panel size. TRT margin is a annuity math problem. A small per-refill software fee difference compounds over years of therapy.

Planning hormone margin with visible per-vial cost

Fizy Health shows resolved per-vial 503A cost on each hormone line in catalog and cart before checkout, with a disclosed facilitation fee at payment and no percentage software fee on transactions. For TRT and HRT programs, that lets you model long-horizon margin from numbers you can read today and batch recurring refills in one clinic cart with per-line cost before one payment.

Compare twelve-month all-in hormone cost: Refill's confirmed aggregate rates plus software fees across your panel against visible pass-through cost plus facilitation fee on the same SKUs and cadence. Rate stability and fee structure matter as much as the starting per-vial quote.

Lock hormone rates at demo — or read them every refill?

Refill fits if

Refill

Aggregate hormone leverage plus infrastructure justify long-horizon demo diligence.

  • Pre-negotiated hormone rates beat your solo contracts after software fees across your TRT panel.
  • You need Refill Connect or outsourced prescribing and accept recurring transaction fees.
  • Meet-or-beat terms cover your hormone formulary with written rate stability across refill cycles.
Consider Fizy Health if

Fizy Health

You run TRT in-house and need per-vial cost visible every refill.

  • You prescribe hormones in-house and model TRT margin from visible per-vial cost before checkout.
  • You want to avoid percentage software fees compounding on every monthly hormone refill.
  • You batch multi-patient TRT refill days in one cart with per-line cost before payment.
FAQ

What clinics ask about Refill hormone and TRT pricing.

  • Pricing

    Does Refill publish hormone and TRT prices?

    No. Refill does not publish per-vial hormone prices on refill.co. Hormone and TRT cost flows through aggregate pre-negotiated 503A rates plus transaction software fees, confirmed at demo and onboarding.

  • Stability

    Do Refill hormone rates stay fixed across refill cycles?

    Confirm in writing at demo. Aggregate rates may be subject to renegotiation at volume tiers or meet-or-beat term expiration. TRT programs need rate stability across years of therapy.

  • Panels

    How do multi-line hormone panels affect cost on Refill?

    Each line carries its own aggregate medication rate, and software fees apply to the transaction. Multi-SKU TRT panels compound software fee dollars per patient per cycle.

  • Fees

    Do software fees matter on monthly TRT refills?

    Yes. Percentage software fees on every recurring hormone refill compound over a patient's years on therapy. Model twelve-month all-in cost, not just the first refill quote.

  • Comparison

    How does Fizy Health handle hormone pricing?

    Fizy Health shows resolved per-vial 503A cost on each hormone line before checkout with a disclosed facilitation fee and no percentage transaction fee, supporting long-horizon TRT margin planning.

  • Diligence

    What hormone questions belong in a Refill demo?

    Written per-vial cost on your full TRT or HRT panel, rate stability across refill cycles, software fee tier, meet-or-beat terms on hormone SKUs, and shipping rules for injectable therapies.

Sources reviewed June 2026

  • Refill public website and published pricing tiers in Refill web app (refill.co), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Plan TRT margin on cost you can read every refill.

Compare hormone landed cost across your panel, batch recurring refills, and model long-horizon economics. Free to start.